Principal Financial Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,408
| Closed | -$48.1K | – | 2244 |
|
|
2024
Q2 | $48.1K | Sell |
11,408
-9,884
| -46% | -$41.7K | ﹤0.01% | 2288 |
|
|
2024
Q1 | $108K | Buy |
21,292
+428
| +2% | +$2.18K | ﹤0.01% | 2262 |
|
|
2023
Q4 | $194K | Buy |
20,864
+204
| +1% | +$1.9K | ﹤0.01% | 2175 |
|
|
2023
Q3 | $135K | Sell |
20,660
-295
| -1% | -$1.93K | ﹤0.01% | 2226 |
|
|
2023
Q2 | $170K | Buy |
20,955
+1,690
| +9% | +$13.7K | ﹤0.01% | 2206 |
|
|
2023
Q1 | $165K | Sell |
19,265
-1,439
| -7% | -$12.3K | ﹤0.01% | 2218 |
|
|
2022
Q4 | $192K | Buy |
20,704
+1,962
| +10% | +$18.2K | ﹤0.01% | 2206 |
|
|
2022
Q3 | $194K | Sell |
18,742
-393
| -2% | -$4.07K | ﹤0.01% | 2213 |
|
|
2022
Q2 | $192K | Buy |
19,135
+6,853
| +56% | +$68.8K | ﹤0.01% | 2305 |
|
|
2022
Q1 | $151K | Buy |
12,282
+874
| +8% | +$10.7K | ﹤0.01% | 2384 |
|
|
2021
Q4 | $198K | Sell |
11,408
-15,790
| -58% | -$274K | ﹤0.01% | 2369 |
|
|
2021
Q3 | $488K | Buy |
27,198
+1,234
| +5% | +$22.1K | ﹤0.01% | 2178 |
|
|
2021
Q2 | $594K | Buy |
25,964
+13,509
| +108% | +$309K | ﹤0.01% | 2167 |
|
|
2021
Q1 | $186K | Sell |
12,455
-1,240
| -9% | -$18.5K | ﹤0.01% | 2388 |
|
|
2020
Q4 | $74K | Buy |
+13,695
| New | +$74K | ﹤0.01% | 2377 |
|